Literature DB >> 30834552

Maturational changes in vancomycin protein binding affect vancomycin dosing in neonates.

Stéphanie Leroux1,2, Johannes N van den Anker1,3, Anne Smits4,5, Marc Pfister1,6, Karel Allegaert5,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30834552      PMCID： PMC6475736          DOI： 10.1111/bcp.13899

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  9 in total

1.  Unanswered Questions Regarding Optimal Pediatric Vancomycin Use.

Authors:  Chris Stockmann; Helen Sammons; Elizabeth Starkey; Jonathan E Constance; Catherine M T Sherwin
Journal:  Ther Drug Monit       Date:  2016-06       Impact factor: 3.681

2.  Maturational changes in vancomycin protein binding affect vancomycin dosing in neonates.

Authors:  Stéphanie Leroux; Johannes N van den Anker; Anne Smits; Marc Pfister; Karel Allegaert
Journal:  Br J Clin Pharmacol       Date:  2019-03-04       Impact factor: 4.335

3.  External Evaluation of Population Pharmacokinetic Models of Vancomycin in Neonates: The transferability of published models to different clinical settings.

Authors:  Wei Zhao; Florentia Kaguelidou; Valérie Biran; Daolun Zhang; Karel Allegaert; Edmund V Capparelli; Nick Holford; Toshimi Kimura; Yoke-Lin Lo; José-Esteban Peris; Alison Thomson; John N van den Anker; May Fakhoury; Evelyne Jacqz-Aigrain
Journal:  Br J Clin Pharmacol       Date:  2013-04       Impact factor: 4.335

4.  Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections.

Authors:  Pamela A Moise-Broder; Alan Forrest; Mary C Birmingham; Jerome J Schentag
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

5.  Duration of vancomycin treatment for coagulase-negative Staphylococcus sepsis in very low birth weight infants.

Authors:  Nehama Linder; Daniel Lubin; Adriana Hernandez; Limor Amit; Shai Ashkenazi
Journal:  Br J Clin Pharmacol       Date:  2013-07       Impact factor: 4.335

6.  Factors impacting unbound vancomycin concentrations in neonates and young infants.

Authors:  Anne Smits; Steven Pauwels; Matthijs Oyaert; Nele Peersman; Isabel Spriet; Veroniek Saegeman; Karel Allegaert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-16       Impact factor: 3.267

7.  Renal drug clearance in preterm neonates: relation to prenatal growth.

Authors:  Karel Allegaert; Brian J Anderson; John N van den Anker; Sophie Vanhaesebrouck; Francis de Zegher
Journal:  Ther Drug Monit       Date:  2007-06       Impact factor: 3.681

Review 8.  Use of antibacterial agents in the neonate: 50 years of experience with vancomycin administration.

Authors:  Evelyne Jacqz-Aigrain; Wei Zhao; Mike Sharland; John N van den Anker
Journal:  Semin Fetal Neonatal Med       Date:  2012-11-06       Impact factor: 3.926

9.  Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?

Authors:  Helgi Padari; Kersti Oselin; Tõnis Tasa; Tuuli Metsvaht; Krista Lõivukene; Irja Lutsar
Journal:  BMC Pediatr       Date:  2016-12-08       Impact factor: 2.125
  9 in total
  6 in total

1.  Clinical Significance of the Plasma Protein Binding of Rifampicin in the Treatment of Tuberculosis Patients.

Authors:  Roger K Verbeeck; Bonifasius S Singu; Dan Kibuule
Journal:  Clin Pharmacokinet       Date:  2019-12       Impact factor: 6.447

2.  Maturational changes in vancomycin protein binding affect vancomycin dosing in neonates.

Authors:  Stéphanie Leroux; Johannes N van den Anker; Anne Smits; Marc Pfister; Karel Allegaert
Journal:  Br J Clin Pharmacol       Date:  2019-03-04       Impact factor: 4.335

3.  Population Pharmacokinetic Analysis and Dose Regimen Optimization in Japanese Infants with an Extremely Low Birth Weight.

Authors:  Hiroshi Sasano; Kanon Aoki; Ryutarou Arakawa; Kazuhiko Hanada
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

4.  Variation in vancomycin dosing and therapeutic drug monitoring practices in neonatal intensive care units.

Authors:  Anouk van der Veen; Annemie Somers; Sophie Vanhaesebrouck; Rob Ter Heine; Roger Brüggemann; Karel Allegaert; Pieter De Cock
Journal:  Int J Clin Pharm       Date:  2021-11-02

Review 5.  Stratified Management for Bacterial Infections in Late Preterm and Term Neonates: Current Strategies and Future Opportunities Toward Precision Medicine.

Authors:  Fleur M Keij; Niek B Achten; Gerdien A Tramper-Stranders; Karel Allegaert; Annemarie M C van Rossum; Irwin K M Reiss; René F Kornelisse
Journal:  Front Pediatr       Date:  2021-04-01       Impact factor: 3.418

6.  Population Pharmacokinetics of Vancomycin in Pregnant Women.

Authors:  Rahul K Goyal; Brady S Moffett; Jogarao V S Gobburu; Mayar Al Mohajer
Journal:  Front Pharmacol       Date:  2022-06-06       Impact factor: 5.988
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.